Logo image of SDGR

SCHRODINGER INC (SDGR) Stock Fundamental Analysis

NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD

19.36  -0.04 (-0.21%)

After market: 19.8556 +0.5 (+2.56%)

Fundamental Rating

4

Taking everything into account, SDGR scores 4 out of 10 in our fundamental rating. SDGR was compared to 35 industry peers in the Health Care Technology industry. While SDGR has a great health rating, there are worries on its profitability. While showing a medium growth rate, SDGR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SDGR has reported negative net income.
In the past year SDGR had a positive cash flow from operations.
SDGR had negative earnings in 4 of the past 5 years.
SDGR had negative operating cash flow in 4 of the past 5 years.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.35%, SDGR is doing worse than 62.86% of the companies in the same industry.
The Return On Equity of SDGR (-52.89%) is worse than 62.86% of its industry peers.
Industry RankSector Rank
ROA -26.35%
ROE -52.89%
ROIC N/A
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

SDGR's Gross Margin of 58.48% is in line compared to the rest of the industry. SDGR outperforms 54.29% of its industry peers.
SDGR's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SDGR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

7

2. Health

2.1 Basic Checks

SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SDGR has been increased compared to 1 year ago.
SDGR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that SDGR is in the distress zone and has some risk of bankruptcy.
SDGR has a Altman-Z score (1.24) which is in line with its industry peers.
There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.24
ROIC/WACCN/A
WACC10.21%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SDGR has a Current Ratio of 3.30. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
SDGR has a better Current ratio (3.30) than 77.14% of its industry peers.
SDGR has a Quick Ratio of 3.30. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.30, SDGR is in the better half of the industry, outperforming 77.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 3.3
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

SDGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.47%, which is quite good.
Looking at the last year, SDGR shows a quite strong growth in Revenue. The Revenue has grown by 18.59% in the last year.
SDGR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.41% yearly.
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.27%
Revenue 1Y (TTM)18.59%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%15.69%

3.2 Future

SDGR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.50% yearly.
SDGR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.32% yearly.
EPS Next Y-4.56%
EPS Next 2Y8.61%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue Next Year25.2%
Revenue Next 2Y23.68%
Revenue Next 3Y21.1%
Revenue Next 5Y20.32%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SDGR. In the last year negative earnings were reported.
Also next year SDGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as SDGR.
Industry RankSector Rank
P/FCF 58.29
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

SDGR's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.61%
EPS Next 3Y13.5%

More info and screens

0

5. Dividend

5.1 Amount

SDGR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCHRODINGER INC

NASDAQ:SDGR (8/20/2025, 8:23:45 PM)

After market: 19.8556 +0.5 (+2.56%)

19.36

-0.04 (-0.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners101.98%
Inst Owner Change6.91%
Ins Owners2.65%
Ins Owner Change2.41%
Market Cap1.42B
Analysts82.67
Price Target31.85 (64.51%)
Short Float %14.95%
Short Ratio7.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.6%
Min EPS beat(2)-7.46%
Max EPS beat(2)24.66%
EPS beat(4)2
Avg EPS beat(4)0.77%
Min EPS beat(4)-28.59%
Max EPS beat(4)24.66%
EPS beat(8)4
Avg EPS beat(8)-0.84%
EPS beat(12)8
Avg EPS beat(12)15.13%
EPS beat(16)9
Avg EPS beat(16)10.08%
Revenue beat(2)2
Avg Revenue beat(2)5.03%
Min Revenue beat(2)3.23%
Max Revenue beat(2)6.83%
Revenue beat(4)3
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-14.72%
Max Revenue beat(4)6.83%
Revenue beat(8)5
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)2.42%
Revenue beat(16)10
Avg Revenue beat(16)5.56%
PT rev (1m)-1.75%
PT rev (3m)-2.43%
EPS NQ rev (1m)4.41%
EPS NQ rev (3m)3.67%
EPS NY rev (1m)0%
EPS NY rev (3m)1.68%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)-5.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.97
P/FCF 58.29
P/OCF 51.67
P/B 4.14
P/tB 4.2
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)-2.11
Fwd EYN/A
FCF(TTM)0.33
FCFY1.72%
OCF(TTM)0.37
OCFY1.94%
SpS3.24
BVpS4.67
TBVpS4.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.35%
ROE -52.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.48%
FCFM 10.24%
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 48.51%
Cap/Sales 1.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 3.3
Altman-Z 1.24
F-Score5
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.27%
EPS Next Y-4.56%
EPS Next 2Y8.61%
EPS Next 3Y13.5%
EPS Next 5YN/A
Revenue 1Y (TTM)18.59%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%15.69%
Revenue Next Year25.2%
Revenue Next 2Y23.68%
Revenue Next 3Y21.1%
Revenue Next 5Y20.32%
EBIT growth 1Y6.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.46%
EBIT Next 3Y17.64%
EBIT Next 5YN/A
FCF growth 1Y121.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.23%
OCF growth 3YN/A
OCF growth 5YN/A